Migraine in Adolescents
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Dec 6, 2022
Trial Information
Current as of January 17, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Migraine in Adolescents," is focused on understanding migraines in young people aged 10 to 13. The researchers aim to find out what factors might predict when a migraine will start, what changes happen in the body and brain during a migraine, and how these factors can help predict how well a young person with migraines will do in the future. The study is currently recruiting participants who either have migraines or are healthy but have a family history of migraines.
To be eligible for the trial, participants must be between 10 and 13 years old, and if they have migraines, they should have been experiencing them for more than six months. Healthy participants should not have any migraine symptoms and must have a first-degree relative (like a parent or sibling) diagnosed with migraines. Participants will undergo assessments to help researchers gather information, but they should not have other chronic pain conditions or disorders that could interfere with the study. This research could help improve understanding and treatment of migraines in adolescents, making it an important opportunity for those who qualify.
Gender
ALL
Eligibility criteria
- Inclusion criteria for healthy participants:
- • 1. Age 10-13
- • 2. Males or females (biological sex)
- • 3. Not diagnosed with migraine or having migraine symptoms
- • 4. With a first degree relative diagnosed with migraine (for the Fam-His group) or without a first or a second degree relative diagnosed with migraine (for the No-Fam-His group)
- Inclusion criteria for participants with migraine:
- • 1. Age 10-13
- • 2. Males or females (biological sex)
- • 3. Diagnosed with migraine or having migraine symptoms
- • 4. Migraine duration \> 6 months
- • 5. Without preventative treatment or with stable preventative treatment for migraine (no change in intervention in the last 6 months)
- Exclusion Criteria for the healthy group:
- * Participants will not be enrolled if any of the following criteria exist and based on the investigator discretion:
- • 1. Diagnosis of any chronic pain syndrome
- • 2. Diagnosis of a neurological, developmental, pubertal, or psychiatric disorder
- • 3. Taking pain or psychiatric medications regularly
- • 4. Having an MRI contraindication such as metal in the body or claustrophobia
- • 5. Not able to understand and communicate in English
- • Exclusion Criteria for the migraine group
- * Participants will not be enrolled if any of the following criteria exist and based on the investigator discretion:
- • 1. Diagnosis of any chronic pain syndrome other than migraine
- • 2. Diagnosis of a neurological, developmental, pubertal, or psychiatric disorder
- • 3. Having an MRI contraindication such as metal in the body or claustrophobia
- • 4. Not able to understand and communicate in English
Trial Officials
Hadas Nahman-Averbuch, PhD
Principal Investigator
Washington University School of Medicine
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Saint Louis, Missouri, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials